Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on March 1, 2016. The filing serves as a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a cover sheet referencing a press release rather than containing detailed financial statements.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. The document references Exhibit 99.1, a press release dated March 1, 2016, which likely contains the specific details of the event being reported.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The content is limited to the cover page and signature block of the registrant.
Key Facts for Investor Verification
- Verify the content of Exhibit 99.1 (Press Release dated March 1, 2016) to understand the specific event triggering this filing.
- Confirm the company's status as a registrant filing under Form 20-F.
- Note that the Chief Executive Officer, André Choulika, signed the report on behalf of the registrant.